What we do
The Computational Systems Oncology lab integrates algorithmic design, numerical modelling, and molecular biology approaches to address relevant questions in cancer biology and therapeutics. We explore single and combinations of genetic and epigenetic alterations that emerge and are selected during cancer evolution, to understand cancer driving mechanisms and inform precision medicine approaches.
Main publications 2017
- Mina M et al. Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies. Cancer Cell, 32(2), 155-168 2017
- Oricchio E et al. Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma, Science Trans. Med., 9, 396 2017
Find out more about the Group’s activities
